GetWell Health
114 George L Davis Boulevard · Nashville, TN 37203
4.8(52 Google reviews · 5 in past year)
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
114 George L Davis Boulevard · Nashville, TN 37203
4.8(52 Google reviews · 5 in past year)
205 29th Avenue North · Nashville, TN 37203
4.7(39 Google reviews · 4 in past year)
719 Thompson Lane · Nashville, TN 37204
2.7(35 Google reviews · 3 in past year)
5505 Edmondson Pike · Nashville, TN 37211
5.0(16 Google reviews · 16 in past year)
4822 Old Hickory Boulevard · Nashville, TN 37076
5.0(13 Google reviews · 2 in past year)
248 A Jackson Meadows Drive · Nashville, TN 37076
5.0(7 Google reviews)
3443 Dickerson Pike · Nashville, TN 37207
Pins reflect street addresses where available; others are approximate (ZIP-level).
Be first to know when its status changes — join thousands already on the list.
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Nashville or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 18 of the 30 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Tennessee residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.